Qiming Venture Partners
Qiming Venture Partners is a venture capital firm investing in the TMT and healthcare industries at the early and growth stages.
Business Model:
Revenue: $8.1M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Qiming Venture Partners Information
Geographic Data
Address: Room3906 Jinmao Tower
City: Shanghai
State: shanghai municipality
Zip: 200121
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$9B
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
2,312,265Website Global Rank
8,132Website Monthly Traffic
Twitter Followers
Description
Qiming Venture Partners is a venture capital firm that specializes in building new companies in China. Since their establishment, they have been investing in the TMT and healthcare industries at the early and growing stages. Founded in 2006 by Gary Rieschel, Qiming Venture Partners based in Shanghai, Shanghai.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2019 | Plum | Series B | 0 |
| 9/2018 | Aohua | Series D | 43.7M |
| 1/2016 | Aohua | Series C | 30.8M |
| 3/2018 | V Light | Seed Round | 1M |
| 7/2015 | Lanmi | Series A | 5M |
| 4/2022 | Rhino Health | Venture Round | 5.7M |
| 6/2013 | VINNO Technology | Series A | 5.8M |
| 8/2017 | Antengene Corporation | Series A | 21M |
| 7/2020 | New Horizon Health | Series E | 30M |
| 7/2018 | dMed | Series B | 6M |
| 1/2020 | Chushou | Debt Financing | 4M |
| 3/2019 | ACEA BIO | Venture Round | 20M |
| 7/2010 | Sangon Biotech | Series A | 6.2M |
| 1/2018 | Chushou | Series D | 47.5M |
| 2/2017 | Anxin Doctor | Series B | 29.1M |
| 2/2017 | Anssure Pharma | Series A | 8.7M |
| 4/2020 | Belief Biomed | Series B | 84M |
| 3/2008 | Touchmedia | Series B | 14.2M |
| 9/2017 | VR Medical | Series B | 3M |
| 4/2021 | Unisound | Series D | 60M |
| 2/2021 | Saints Sages Medical | Series A | 18.6M |
| 11/2021 | Micropace | Series A | 5.5M |
| 8/2006 | Touchmedia | Series A | - |
| 9/2019 | Tisenc | Series B | 11.2M |
| 3/2015 | Insta360 | Series A | 8M |
| 8/2018 | APT Medical | Series B | 11.1M |
| 12/2017 | Cehome | Series D | 44M |
| 1/2005 | Gammastar Medical Group | Series A | 8.7M |
| 5/2021 | IntoCare | Series D | 43.2M |
| 5/2021 | Data Transmission Group | Secondary Market | 9.3M |
| 8/2018 | Cool Math | Series A | 10M |
| 5/2010 | ChinaCache | Post-IPO Equity | - |
| 11/2021 | Beijing Okeanos Technology | Series B | 22.4M |
| 8/2021 | Superhexa | Seed Round | 9.9M |
| 12/2021 | Superhexa | Series A | 28M |
| 12/2019 | Yuanxin Huibao | Series A | 4.3M |
| 10/2013 | Dajiabao | Series A | - |
| 12/2013 | Shanghai Rendu Biotechnology | Series B | 10.3M |
| 5/2014 | Meitu | Series B | 115M |
| 8/2022 | Oricell Therapeutics | Series B | 120M |
| 9/2007 | Juren Educational | Venture Round | 20M |
| 10/2017 | SGEET | Series A | 7.5M |
| 10/2016 | Broncus Technologies | Series A | 12.2M |
| 7/2018 | ZEGOCLOUD | Series B | 16M |
| 5/2013 | Cehome | Series A | 2M |
| 6/2011 | Novast | Series C | 2.9M |
| 1/2021 | Oricell Therapeutics | Series A | 0 |
| 4/2015 | HaiRun Pictures | Series A | 11.3M |
| 1/2021 | RFoneTech | Series A | 4.6M |
| 8/2017 | Kintep Environmental | Series B | 5.6M |
| 5/2021 | MeetFuture China | Series A | 12.3M |
| 11/2010 | Guokang Health Management | Series B | 14.9M |
| 8/2018 | Plum | Series B | 21.4M |
| 10/2017 | Gaiya Environment | Series A | 6.1M |
| 10/2021 | Clounix | Seed Round | 34.9M |
| 5/2018 | Hanqi | Series A | 6.3M |
| 9/2011 | Novast | Series D | 2M |
| 12/2017 | Xiaobu | Series B | 14M |
| 8/2019 | Haoyiku | Series C | 100M |
| 4/2015 | Fortune International Factoring | Series A | 16.2M |
| 7/2019 | Chuman | Series B | 8.7M |
| 11/2017 | Chuman | Series A | 8.3M |
| 5/2021 | Render | Series A | 15.5M |
| 12/2018 | Try Try | Series A | 7M |
| 12/2011 | Appconomy | Series B | 10M |
| 12/2021 | InfStones | Series B | 33M |
| 2/2021 | Morewis | Series B | 9.3M |
| 6/2017 | SinoTau | Series B | 22M |
| 2/2021 | Singular Medical | Series B | 24M |
| 7/2010 | LanzaTech | Series B | 18M |
| 12/2019 | Oricell Therapeutics | Seed Round | 14.2M |
| 4/2017 | CanSinoBIO | Series E | 0 |
| 12/2021 | TUNGEE | Series B | 0 |
| 10/2018 | DST Car | Series B | 47.4M |
| 3/2022 | MeetFuture China | Series B | 0 |
| 7/2020 | Antengene Corporation | Series C | 97M |
| 9/2015 | Oakbarrel | Series B | 3.1M |
| 2/2017 | LIH Investment &a; Management | Series A | 5.8M |
| 4/2017 | IntoCare | Series A | 26M |
| 9/2009 | 60DXchange | Venture Round | - |
| 4/2021 | P&a;R Measurement Technology | Series C | 23.9M |
| 2/2018 | P&a;R Measurement Technology | Series A | 9.9M |
| 1/2020 | DST Car | Series C | - |
| 8/2018 | Kira Pharmaceuticals | Series A | 13M |
| 11/2020 | LaNova Medicines | Series A | 84.4M |
| 3/2020 | Singular Medical | Series A | 10M |
| 8/2016 | Ruhnn Holding Limited | Series C | - |
| 3/2016 | Cehome | Series C | 25M |
| 1/2017 | Diandoc | Seed Round | 1M |
| 9/2017 | TigerGraph | Series A | 31M |
| 9/2009 | Jiayuan | Series B | - |
| 5/2018 | Xueba100.com | Series D | 22.5M |
| 10/2010 | Dang Le | Series A | 12M |
| 11/2018 | Eigen | Series B | 6.6M |
| 2/2009 | Youxigu | Series A | - |
| 4/2016 | AirQuality | Series B | 4M |
| 12/2020 | dMed | Series C | 100M |
| 6/2016 | JunHe | Series B | 7.6M |
| 7/2020 | 52toys | Secondary Market | 2M |
| 3/2019 | 52toys | Series A | 447.3k |
| 3/2018 | 52toys | Series A | 14.6M |
| 4/2020 | DiNovA Medtech | Series C | 17M |
| 4/2017 | ByteDance | Series D | 1B |
| 1/2012 | MOGU | Series B | 10M |
| 4/2017 | ZappRx | Series B | 25M |
| 10/2012 | MOGU | Series C | - |
| 4/2018 | ZD Medical | Series A | 16.7M |
| 12/2016 | dMed | Series A | 8M |
| 7/2021 | Hochuen Medical Technology | Series A | 6.2M |
| 12/2015 | Aerospace Environment | Series A | 1.3M |
| 11/2021 | Genlight | Series B | 31.4M |
| 7/2018 | The Good Stuff | Series B | 50M |
| 8/2014 | Lagou | Series B | 25M |
| 10/2021 | Brise Pharma | Angel Round | 0 |
| 12/2016 | CETA | Series A | 4.4M |
| 11/2010 | Docin | Series B | - |
| 12/2008 | Docin | Series A | 1M |
| 6/2017 | Chaitin Tech | Series A | 4M |
| 6/2019 | Pulsar Technology | Series A | - |
| 1/2020 | Sunny Dental | Series A | 28.7M |
| 6/2015 | Financial Information Management | Series A | 6M |
| 8/2020 | Shukun Technology | Series B | 0 |
| 12/2019 | Chaodian Culture | Series B | 150M |
| 12/2018 | Chaodian Culture | Series A | 5.5M |
| 10/2017 | Castbox | Series A | 12.8M |
| 3/2016 | CashBUS | Series B | 25M |
| 3/2018 | Bouffalo Lab | Series A | 7M |
| 8/2019 | Bondent Technology | Series D | - |
| 9/2013 | Tiangua Online | Series B | 1M |
| 1/2018 | Innostic | Series A | 39.5M |
| 4/2021 | Xizi Education | Series A | 22M |
| 10/2015 | JFK Biotech | Angel Round | 472.7k |
| 12/2009 | CITIC Pharmaceutical | Series D | 1M |
| 5/2021 | Just Medical | Series B | 34M |
| 3/2021 | Fucunbao | Series C | 11.4M |
| 11/2020 | Kira Pharmaceuticals | Venture Round | - |
| 6/2020 | Shukun Technology | Series B | 0 |
| 6/2018 | RENS Energy | Angel Round | 1M |
| 2/2015 | Aerospace Environment | Series A | - |
| 7/2017 | Kuaile Zhihui | Series A | 0 |
| 9/2021 | GYENNO Technologies | Series B | 17.3M |
| 4/2020 | New Horizon Health | Series D | 20M |
| 2/2016 | Transwarp | Series B | 23.6M |
| 1/2015 | Transwarp | Series A | 5.1M |
| 6/2022 | LaNova Medicines | Series B | - |
| 10/2016 | APT Medical | Series A | 3.6M |
| 10/2012 | CooTek | Series B | 8.2M |
| 3/2015 | Ark Biosciences | Series A | - |
| 8/2019 | APT Medical | Venture Round | 27.2M |
| 11/2018 | APT Medical | Series C | 19.2M |
| 7/2016 | UBTech Robotics | Series B | 100M |
| 11/2021 | Suci Technology | Series A | 8.3M |
| 5/2021 | Hope Medicine | Series B | 56M |
| 9/2019 | Yunyinggu | Series C | 22M |
| 6/2021 | Insilico Medicine | Series C | 0 |
| 6/2011 | Domob | Series B | 20M |
| 4/2018 | Castbox | Series B | 13.5M |
| 4/2020 | Yunyinggu | Series C | 28.2M |
| 12/2015 | Nurotron Biotechnology | Series C | - |
| 10/2015 | Luoji Siwei | Series B | - |
| 4/2020 | Chuhang Tech | Series A | 6.4M |
| 4/2021 | Sincere Edu | Series A | 13M |
| 11/2021 | Shanzhen | Series D | 17M |
| 9/2019 | Shanzhen | Series D | 30M |
| 5/2022 | AskGene Pharma | Series A | 20M |
| 12/2018 | YI Technology | Venture Round | 10M |
| 7/2020 | TUNGEE | Series B | 17.2M |
| 4/2012 | Dang Le | Series B | 20M |
| 11/2020 | Nice Tuan | Series C | 0 |
| 5/2011 | Crown Bioscience | Venture Round | 1M |
| 11/2021 | Atom Semiconductor | Venture Round | 12M |
| 4/2015 | UBTech Robotics | Series A | - |
| 11/2020 | ZEGOCLOUD | Venture Round | 50M |
| 3/2020 | NVX Clouds Tech | Series A | 3.9M |
| 5/2015 | MedSci | Series A | 14.9M |
| 8/2018 | Chaodian Culture | Angel Round | - |
| 4/2020 | Pratilipi | Series C | 0 |
| 4/2018 | Miaoshou Doctor | Series C | 79.6M |
| 8/2019 | Webuy Group | Series C | 100M |
| 9/2016 | Meituan Bike | Series C | - |
| 9/2018 | Tuhu | Series E | 0 |
| 6/2017 | Meituan Bike | Series E | 600M |
| 1/2021 | Yunji Technology | Series C | 0 |
| 12/2009 | ChinaCache | Series D | - |
| 1/2017 | Meituan Bike | Series D | 215M |
| 5/2015 | Tongdun Technology | Series B | 30M |
| 3/2021 | Hangzhou Weier | Series B | 15.5M |
| 4/2022 | Onechip Bioelectronics | Series B | 23.5M |
| 2/2022 | BUD | Series A | 15M |
| 1/2012 | Timesafer | Series A | - |
| 4/2007 | ChinaCache | Series B | 31.5M |
| 4/2018 | Chaodian Culture | Series A | 12.6M |
| 4/2021 | Tasogare | Series B | 41.1M |
| 9/2015 | Roborock | Angel Round | - |
| 8/2017 | ARMO BioSciences | Series C | 0 |
| 5/2019 | Chuhang Tech | Series A | 4.5M |
| 11/2021 | Zeen Health | Venture Round | 6.3M |
| 5/2021 | TUNGEE | Venture Round | 148M |
| 3/2007 | PPS | Series B | 10M |
| 12/2017 | Mafengwo | Series D | 133M |
| 3/2016 | SharpSpring | Post-IPO Equity | - |
| 12/2013 | Nurotron Biotechnology | Series C | 16.2M |
| 5/2019 | New Horizon Health | Series C | 0 |
| 6/2020 | OriginCell | Series A | 8.4M |
| 6/2007 | ICE Entertainment | Series A | 8.5M |
| 7/2022 | Biotree | Series A | 13.3M |
| 3/2021 | Newsoara | Series C | 7M |
| 7/2018 | AI Prime | Angel Round | 1M |
| 7/2018 | Core Medical | Series A | 4.4M |
| 10/2018 | Akulaku | Series C | 0 |
| 7/2012 | Beijing Centre Biology | Series B | 2.6M |
| 6/2020 | Biren Technology | Series A | 0 |
| 3/2021 | Medilink Therapeutics | Series A | 50M |
| 12/2016 | Cencorp Automation | Series A | 10.5M |
| 10/2019 | Casela | Series A | 16.7M |
| 1/2022 | Deep View Technology | Series B | - |
| 9/2022 | Supervision Technology | Seed Round | - |
| 4/2016 | FraudMetrix | Series C | - |
| 6/2015 | Shenogen Pharma Group | Series D | 2.1M |
| 12/2019 | DiNovA Medtech | Series C | 24.6M |
| 11/2019 | Liuyi Jiaoyu | Series B | 0 |
| 5/2021 | Yidao Biotechnology | Series C | 61.8M |
| 11/2021 | Tripod Preclinical Research Laboratories | Venture Round | 0 |
| 5/2017 | Jisuyun | Series A | 7.4M |
| 7/2022 | CIX Technology | Seed Round | - |
| 5/2019 | LetsGetChecked | Series B | 0 |
| 3/2019 | Insta360 | Series C | 0 |
| 9/2019 | Insilico Medicine | Series B | 37M |
| 6/2020 | Kingsware | Series A | 14.7M |
| 5/2022 | Point One | Series B | 36.8M |
| 9/2021 | XSKY Data Technology | Series E | 0 |
| 3/2021 | Delta Medical | Series E | 20.1M |
| 8/2019 | Delta Medical | Series C | 7.1M |
| 8/2017 | ABC Fintech | Series A | 30M |
| 7/2021 | Liangyihui | Series C | 55.9M |
| 11/2019 | Nice Tuan | Series B | 60.4M |
| 8/2015 | Linjia.me | Series B | - |
| 12/2016 | ANXIN | Series B | 42.7M |
| 4/2012 | ITutorGroup | Series A | 15M |
| 10/2021 | Cubenergy Technology | Series A | - |
| 3/2021 | YUANBAO TECH | Series C | 80M |
| 8/2012 | CooTek | Series A | 4.2M |
| 2/2021 | Plum | Series B | 9.1M |
| 8/2019 | Huimei Technology | Series C | 30M |
| 12/2014 | LanzaTech | Series D | 0 |
| 8/2021 | WeRide | Secondary Market | 2M |
| 5/2017 | CANbridge Pharmaceuticals | Series B | 25M |
| 6/2016 | AIQI Technology | Venture Round | 7M |
| 12/2021 | Gemsouls | Series A | 4M |
| 1/2021 | Erwan Technology | Series D | - |
| 1/2022 | MKSEMI | Pre-Series A | 12.8M |
| 11/2013 | LanzaTech | Series C | 0 |
| 3/2021 | Casela | Series A | 2.8M |
| 5/2015 | Coohua | Series B | 20M |
| 7/2015 | Bilibili | Series C | 161.4M |
| 9/2007 | Gaoxing Co., Ltd | Series A | - |
| 10/2016 | Bondent Technology | Series A | 9M |
| 8/2010 | BTR | Series A | 1.6M |
| 10/2013 | Unisound | Series A | 16.3M |
| 3/2021 | MediLink-Global | Series A | 36.9M |
| 1/2021 | Cornerstone Robotics | Series A | 17M |
| 12/2021 | PoPop World | Seed Round | 0 |
| 1/2015 | APUS Group | Series B | 100M |
| 11/2006 | Kuwo Science and Technology | Series A | 5.5M |
| 2/2022 | Purui | Seed Round | 15.7M |
| 5/2011 | Gan &a; Lee Pharmaceutical | Series B | 30.2M |
| 4/2021 | ZSHK Laboratories | Series A | 15.5M |
| 1/2020 | DST Car | Series C | - |
| 3/2020 | Berry Oncology | Series A | 10M |
| 2/2012 | Gan &a; Lee Pharmaceutical | Series B | - |
| 6/2013 | Venus MedTech | Series A | 17M |
| 9/2017 | Zaojiu | Series A | 5.2M |
| 3/2018 | Zaojiu | Series A | 4.7M |
| 12/2019 | Woof | Series A | 7M |
| 12/2018 | Woof | Series A | 5.8M |
| 8/2018 | CureGenetics | Series A | 17M |
| 4/2017 | Bomming Vision | Series A | 4.4M |
| 1/2018 | Bomming Vision | Series A | 1.5M |
| 1/2019 | V Light | Series A | 2.5M |
| 5/2014 | VINNO Technology | Series B | 7.7M |
| 9/2021 | V Light | Series A | 7M |
| 6/2009 | Taomee | Series A | - |
| 5/2018 | Tisenc | Series A | 6.3M |
| 2/2023 | Hochuen Medical Technology | Series B | - |
| 9/2021 | PlusLife Biotech | Series A | 14.9M |
| 3/2005 | b2c.cn | Series A | 3M |
| 10/2014 | Coohua | Series A | 4.9M |
| 12/2007 | Topone | Series C | 50M |
| 5/2018 | Philm | Series B | 7M |
| 5/2017 | ET Healthcare | Venture Round | 7M |
| 7/2021 | NEIWAI | Series D | 100M |
| 10/2019 | NEIWAI | Series C | 18M |
| 9/2019 | QwikMatch | Debt Financing | 1.4M |
| 4/2015 | Zai Lab | Series A | 18.3M |
| 1/2007 | Tianyuan Bio-Pharmaceutical | Series A | - |
| 3/2013 | JHT TCM Clinics | Series A | 2.2M |
| 10/2018 | WeRide | Series A | - |
| 3/2015 | BBI Life Sciences | Post-IPO Equity | 10.3M |
| 2/2015 | Helijia | Series C | 50M |
| 8/2022 | Insilico Medicine | Series D | 35M |
| 3/2019 | Gohoo | Series A | 10.6M |
| 11/2015 | Zhihu | Series C | 55M |
| 1/2017 | CooTek | Series D | 66M |
| 1/2023 | Insyce | Series B | 21.8M |
| 8/2013 | LP Amina | Series C | 20M |
| 1/2017 | Bondent Technology | Series B | - |
| 9/2017 | SinoVision Technologies | Series B | 29M |
| 2/2008 | Ether Optronics (Suzhou) Co., Ltd. | Venture Round | - |
| 8/2019 | TUNGEE | Series B | 17.7M |
| 11/2019 | 61Draw.com | Series B | 11M |
| 3/2018 | Infervision | Series B | 47.4M |
| 7/2017 | Qiagen Suzhou Translational Medicine | Series A | 0 |
| 7/2015 | OneAPM | Series C | 26.7M |
| 11/2021 | Cornerstone Robotics | Series B | 0 |
| 1/2021 | Erwan Technology | Series E | - |
| 2/2014 | VANCL | Series G | 100M |
| 10/2019 | Club Factory | Series D | 100M |
| 12/2021 | Wholee | Series B | 69M |
| 6/2019 | 61Draw.com | Series B | 28M |
| 5/2022 | Yike Polymers | Series B | - |
| 9/2021 | Alamar Biosciences | Series B | 80M |
| 1/2015 | Mitralign | Series E | 23M |
| 2/2022 | NFTGo | Pre-Series A | 6.8M |
| 1/2022 | Axera | Series A | 0 |
| 5/2021 | Insight Lifetech | Secondary Market | 18.1M |
| 6/2018 | IDsManager | Series A | 7.8M |
| 7/2018 | Lanjinrong | Series C | 11.6M |
| 5/2020 | Nice Tuan | Series C | 0 |
| 7/2017 | Bingobox | Series A | 14.7M |
| 11/2018 | Chushou | Venture Round | 8.4M |
| 2/2013 | Tujia | Series B | 40M |
| 1/2018 | Bingobox | Series B | 0 |
| 1/2017 | Chushou | Series C | 57.6M |
| 5/2013 | CSD E.P. Water Service | Series B | - |
| 9/2016 | Zuiyou | Series B | 53M |
| 4/2022 | LTZ Therapeutics | Pre-Series A | 17M |
| 11/2018 | Chomp Cloud | Series B | 13.3M |
| 5/2022 | Ashermed | Series B | - |
| 9/2019 | Platelet BioGenesis | Series A | 26M |
| 6/2008 | LP Amina | Series A | 5M |
| 5/2020 | Microtech Medical | Venture Round | 20M |
| 4/2021 | ET Healthcare | Series G | 105M |
| 9/2020 | Delta Medical | Series D | - |
| 6/2015 | Zhejiang JFK | Angel Round | - |
| 4/2014 | Laguo | Series A | 5M |
| 6/2014 | Zhihu | Series B | 22M |
| 1/2023 | Tingsheng Technology | Series B | 14.7M |
| 8/2014 | Zai Lab | Series A | 10M |
| 10/2018 | DST Car | Series B | 43.1M |
| 6/2018 | Alpha Biopharma | Series A | 37M |
| 7/2017 | AFU | Series C | 9.3M |
| 4/2020 | Shulan Health | Series C | 8.5M |
| 8/2017 | SceneRay | Series C | 19.1M |
| 10/2017 | WeRide | Seed Round | - |
| 9/2018 | ET Healthcare | Series C | 17.5M |
| 8/2016 | Xiaoman Technology | Series B | 5.3M |
| 12/2019 | Vongi | Series B | 2.9M |
| 5/2009 | Touchmedia | Series B | 16.2M |
| 9/2017 | Lagou | Series D | 119.2M |
| 12/2021 | Xinchuangyuan Semiconductor | Series A | 75.4M |
| 12/2021 | Yunji Technology | Venture Round | 72.2M |
| 3/2020 | Berry Genomics | Post-IPO Equity | 10M |
| 8/2018 | PangQiu | Series A | 6.1M |
| 5/2021 | Wonderful | Secondary Market | 1.4M |
| 7/2014 | Beijing Richen-Force Science &a; Technology | Series B | 4.5M |
| 12/2017 | Eigen | Series B | 18.5M |
| 1/2008 | Crown Bioscience | Venture Round | - |
| 9/2019 | DST Car | Venture Round | 30M |
| 1/2018 | Berry Genomics | Post-IPO Equity | 122.7M |
| 3/2018 | Frontage Laboratories | Funding Round | 32.4M |
| 3/2020 | IntoCare | Series C | 7M |
| 4/2018 | Bondent Technology | Series C | 12.7M |
| 1/2012 | Qiniu | Series A | - |
| 7/2019 | OneAPM | Venture Round | 1.6M |
| 6/2013 | Iron Armour | Series A | 5M |
| 8/2021 | Houmo.AI | Seed Round | 46M |
| 5/2017 | XSKY Data Technology | Series B | 17.4M |
| 3/2020 | CureGenetics | Series A | 9.5M |
| 11/2012 | YPX Cayman Holdings | Series C | 0 |
| 11/2007 | Dining Secretary | Series B | - |
| 7/2018 | Zuiyou | Series C | 22M |
| 3/2021 | Zhenge Biotech | Series B | 70M |
| 7/2016 | Chaitin Tech | Series A | 4.1M |
| 12/2020 | Compart Systems | Venture Round | 398M |
| 1/2014 | Tuhu | Series B | - |
| 9/2017 | Infervision | Series B | 18.2M |
| 10/2021 | Qingflow | Series B | 11.8M |
| 12/2015 | UBTech Robotics | Series A | 20M |
| 9/2018 | IntoCare | Series B | 3.7M |
| 6/2014 | Inbilin | Series A | 15M |
| 9/2021 | Genevide | Angel Round | 6M |
| 4/2019 | WebComics | Venture Round | 785k |
| 3/2014 | Domob | Series C | 2M |
| 1/2010 | eHi Car Rental | Series B | 18.7M |
| 4/2019 | Anxin Doctor | Series B | 3.6M |
| 2/2015 | Amoy Diagnostics | Series A | 10.7M |
| 1/2014 | VR Medical | Series A | 5.5M |
| 6/2009 | Alltech Medical Systems | Series B | 5M |
| 5/2017 | Jisuyun | Series A | 7.4M |
| 3/2008 | eHi Car Rental | Series A | 5M |
| 7/2015 | CMLabs | Series A | 1.1M |
| 1/2016 | 8kana | Series A | 6M |
| 9/2006 | Alltech Medical Systems | Series A | - |
| 11/2015 | Shanghai Keysino Separation Technology | Series A | 7.9M |
| 12/2010 | wali | Series A | 4.6M |
| 7/2014 | CooTek | Series C | 69.3M |
| 4/2014 | APT Medical | Series A | - |
| 9/2017 | Sino Vision | Series B | 30.6M |
| 8/2011 | Arrail Dental Clinic | Series B | 20M |
| 5/2014 | Ants Technology | Series A | 3.5M |
| 3/2016 | Shanghai Rendu Biotechnology | Series B | 2.3M |
| 8/2018 | Jacobio Pharmaceuticals | Series C | 0 |
| 11/2016 | Yinshiji | Series A | - |
| 3/2010 | Tigermed | Venture Round | 2M |
| 2/2014 | Wacai.com | Series A | 15M |
| 2/2019 | Xiaobu | Series B | 12M |
| 4/2019 | Bomming Vision | Series A | 596k |
| 7/2016 | KingTrol Data | Series A | 4.5M |
| 3/2016 | SMTP Technology | Series A | 3.1M |
| 1/2015 | Zhaolu Tianxia Wang | Series A | 1.6M |
| 7/2016 | Junhetang | Series B | 7.9M |
| 1/2016 | AIQI Technology | Series A | - |
| 11/2016 | Chomp Cloud | Series A | 6M |
| 3/2011 | CSD Beijing Water Affairs Op | Venture Round | - |
| 6/2014 | Ants Technology | Series B | 7M |
| 6/2009 | ConvenientPower HK | Series A | 3M |
| 9/2014 | Tuhu | Series B | 10M |
| 3/2019 | Emergen | Series B | 29.8M |
| 1/2018 | Roborock | Series B | 3.4M |
| 3/2020 | Wuli Planet | Series A | 7.5M |
| 6/2018 | Wuli Planet | Seed Round | 2M |
| 4/2016 | Roborock | Series B | 25M |
| 1/2017 | Connect Biopharmaceuticals | Series A | 20M |
| 7/2018 | Kaiheikeji Digital | Series A | 15M |
| 11/2017 | Kaiheikeji Digital | Series A | 11.5M |
| 1/2011 | CSD E.P. Water Service | Venture Round | - |
| 2/2020 | Fingo | Series A | 7M |
| 4/2017 | Qiang Sen International Community Medical | Series B | 14.6M |
| 10/2018 | DK MedTech | Series B | 8.7M |
| 8/2010 | Jiayuan | Series B | - |
| 5/2015 | Junhetang | Series B | - |
| 9/2016 | Hypereal | Series B | 10.5M |
| 7/2020 | HashQuark | Series A | 2M |
| 8/2010 | 2Duche | Venture Round | - |
| 9/2018 | Bion Interactive Entertainment Company | Seed Round | 2M |
| 3/2008 | Crown Bioscience | Series B | 3.2M |
| 1/2018 | Chaodian Culture | Seed Round | 723.8k |
| 8/2019 | WorkTrans | Series C | 50.5M |
| 2/2010 | Aeonmed Medical Treatment | Series A | 3.5M |
| 10/2017 | Moretickets | Series B | 25M |
| 6/2017 | Platelet BioGenesis | Series A | 0 |
| 5/2019 | Mafengwo | Series E | 0 |
| 9/2021 | Sanegene Bio | Series A | 38M |
| 7/2021 | Kingsware | Series B | 42.4M |
| 2/2020 | Jacobio Pharmaceuticals | Series C | 27M |
| 5/2021 | MKSEMI | Series A | 12.9M |
| 9/2021 | moodytiger | Series B | 20M |
| 6/2016 | VeeR (Velocious) | Seed Round | 2M |
| 8/2018 | CANbridge Pharmaceuticals | Series C | 38.1M |
| 7/2019 | Xiudan | Seed Round | - |
| 9/2011 | Slanissue | Venture Round | 10M |
| 1/2019 | Zion Pharma | Series A | 11.9M |
| 8/2020 | Zion Pharma | Series A | 20M |
| 5/2019 | Hesai Technology | Series C | 37M |
| 8/2022 | Prismlab China Ltd | Series C | 29.1M |
| 12/2014 | Unisound | Series B | 50M |
| 9/2016 | OneAPM | Series D | 19.5M |
| 4/2017 | Berry Genomics | Funding Round | 8.1M |
| 2/2019 | Nuvaira | Equity | 79M |
| 5/2008 | Kuwo Science and Technology | Series B | - |
| 7/2014 | Intelligent Automation | Series B | 4.2M |
| 4/2009 | Kaixin001 | Series B | 20M |
| 1/2008 | PPS | Series C | 20M |
| 8/2008 | VANCL | Series D | 30M |
| 12/2016 | Luo Tianyi | Series B | 8M |
| 7/2018 | Wacai.com | Series D | 140M |
| 5/2021 | Health Biotech | Series B | 34.5M |
| 7/2016 | CooTek | Series D | 46M |
| 5/2021 | TUNGEE | Series C | 148M |
| 9/2018 | Cubenergy Technology | Series A | 7.3M |
| 3/2015 | CashBUS | Series A | - |
| 4/2021 | Castbox | Series C | 15M |
| 7/2016 | LIH Investment &a; Management | Series A | 12M |
| 4/2016 | CanSinoBIO | Venture Round | 11M |
| 3/2018 | Jisuyun | Series B | 11.4M |
| 6/2019 | ZD Medical | Series A | 4.5M |
| 12/2009 | Gan &a; Lee Pharmaceutical | Series A | 16.2M |
| 4/2021 | ROX Motor | Series A | 60M |
| 11/2018 | Reelsky Data Systems | Series A | 5.4M |
| 12/2018 | FirstGrid | Seed Round | 4.8M |
| 3/2018 | Chaonengjie | Seed Round | 2.8M |
| 1/2018 | Xiaoman Technology | Series C | 9.7M |
| 12/2009 | LP Amina | Series B | 9.4M |
| 4/2016 | Tongdun Technology | Series B | 32M |
| 4/2007 | Jiayuan | Series A | 5.4M |
| 4/2021 | Zion Pharma | Series B | 37M |
| 11/2018 | Haoyiku | Series B | - |
| 4/2016 | Tiebaobei | Series C | 30.9M |
| 4/2021 | Booming Technologies | Series C | 56M |
| 5/2019 | Nice Tuan | Series A | 27.9M |
| 3/2015 | Venus MedTech | Series B | 8M |
| 9/2017 | Venus MedTech | Series C | 7.4M |
| 1/2020 | Nice Tuan | Series B | 88.3M |
| 6/2013 | Intelligent Automation | Series A | 5.1M |
| 11/2017 | Bioscience | Series C | 15.6M |
| 11/2020 | Yunyinggu | Series D | 45.6M |
| 5/2017 | Vongi | Series A | 6M |
| 6/2021 | Xiaoe Tech | Series D | 120M |
| 6/2015 | SMTP Technology | Series A | 8.1M |
| 5/2018 | The Makers | Series B | 8.5M |
| 3/2013 | Sino MDT | Series A | 4M |
| 5/2018 | Sino Biological | Venture Round | 15.8M |
| 2/2012 | Shanghai Tellgen Life Science | Series A | 5M |
| 7/2017 | Kira Pharmaceuticals | Series A | 5M |
| 3/2020 | Structure Therapeutics | Series A | 26M |
| 7/2014 | MEGVII | Series B | 22M |
| 3/2022 | BlockVision | Seed | 5M |
| 9/2021 | WOWJOY TECHNOLOGY | Series A | 13.6M |
| 3/2022 | ACXEL Tech | Seed Round | 0 |
| 9/2017 | ABC Fintech | Series A | 30M |
| 3/2018 | ACEA BIO | Series E | 15M |
| 12/2021 | DP Technology | Series B | 43.7M |
| 8/2018 | Koala Reading | Series B | 20M |
| 8/2014 | Laguo | Series B | 25M |
| 2/2020 | Kira Pharmaceuticals | Series B | 28M |
| 10/2011 | YPX Cayman Holdings | Series B | 20M |
| 12/2017 | Koala Reading | Series A | 10M |
| 2/2022 | WOWJOY TECHNOLOGY | Series A | 10M |
| 5/2011 | Crown Bioscience | Series C | 28.8M |
| 2/2012 | Touchmedia | Series C | 16.2M |
| 7/2022 | Chatail | Series B | 10M |
| 8/2022 | DeepWay | Series A | 67.2M |
| 8/2017 | Chomp Cloud | Series A | 7M |
| 2/2021 | Miaoshou Doctor | Series E | 0 |
| 6/2012 | Forgame | Private Equity Round | 68.8M |
| 4/2007 | Huan Xiong | Venture Round | 1.8M |
| 1/2016 | Zai Lab | Series B | 106.2M |
| 5/2022 | BUD | Series B | 0 |
| 7/2017 | OPUS | Angel Round | 1M |
| 5/2010 | Mutto Optronics | Venture Round | - |
| 10/2017 | Jacobio Pharmaceuticals | Venture Round | 19.6M |
| 5/2010 | 7k7k.com | Angel Round | 1.1M |
| 12/2017 | Meituan Bike | Corporate Round | - |
| 7/2018 | Qingqi Technology | Angel Round | - |
| 11/2018 | Guji Information | Angel Round | 287.9k |
| 11/2011 | Leho | Venture Round | 50M |
| 8/2015 | Tuhu | Series C | 0 |
| 4/2022 | Clique | Seed Round | - |
| 4/2016 | Xueda | Post-IPO Equity | - |
| 8/2019 | RedDoorz | Series C | 0 |
| 12/2016 | MEGVII | Series C | 100M |
| 3/2016 | Lagou | Series C | 34M |
| 1/2016 | Qiniu | Series D | 100M |
| 12/2019 | KeChow Pharma | Series C | 45M |
| 4/2011 | Dazhong Dianping | Series C | 100M |
| 10/2020 | Broncus Technologies | Series C | - |
| 9/2019 | TigerGraph | Series B | 32M |
| 4/2018 | CMLabs | Series C | 15.9M |
| 10/2013 | BSC | Series A | 1.6M |
| 4/2014 | Arrail Dental Clinic | Series C | 70M |
| 10/2014 | WeDoctor | Series B | 106.5M |
| 4/2019 | Talaris Therapeutics | Series A | 100M |
| 7/2022 | PwnedNoMore | Seed Round | - |
| 4/2018 | Wuxi Vision Pro | Series B | 14.2M |
| 7/2021 | Zion Pharma | Series B | 40M |
| 2/2013 | Qiniu | Series B | 4.2M |
| 5/2015 | FraudMetrix | Series B | 30M |
| 12/2017 | QwikMatch | Series B | 6M |
| 6/2020 | Miaoshou Doctor | Series D | 85M |
| 10/2018 | NASN Automotive Electronics | Series A | 14.4M |
| 1/2017 | Microtech Medical | Series B | 12.2M |
| 6/2019 | Liuyi Jiaoyu | Series B | 2.9M |
| 1/2022 | CureGenetics | Series B | 0 |
| 11/2021 | Allorion Therapeutics | Series A | 0 |
| 1/2017 | Xueba100.com | Series C | 100M |
| 2/2015 | Xueba100.com | Series B | 50M |
| 1/2019 | Connect Biopharmaceuticals | Series B | 55M |
| 6/2018 | WindMIL Therapeutics | Series B | 0 |
| 11/2018 | Cadent Therapeutics | Series B | 40M |
| 10/2018 | CardiaLen | Series B | 17M |
| 10/2020 | Cool Academy | Series A | 15M |
| 8/2021 | Berry Oncology | Series B | 99.2M |
| 12/2014 | Wacai.com | Series B | 50M |
| 3/2021 | Cool Academy | Series B | 18.9M |
| 1/2013 | Tuhu | Series A | - |
| 7/2019 | Yuanxin Huibao | Series A | 7.3M |
| 10/2008 | Novast | Series B | 50M |
| 4/2019 | Mech-Mind | Series A | 50M |
| 4/2018 | XSKY Data Technology | Series C | 37.8M |
| 2/2020 | Bouffalo Lab | Series B | 26M |
| 6/2014 | Tujia | Series C | 100M |
| 9/2021 | Sunyur | Series B | 0 |
| 5/2020 | Alamar Biosciences | Series A | 14M |
| 10/2007 | Guokang Health Management | Series A | 10M |
| 4/2013 | Shenzhen LETEL Technology | Series A | 5.9M |
| 8/2022 | GluBio Therapeutics | Series A | 22M |
| 9/2017 | Hypereal | Series C | 11.8M |
| 6/2017 | MyHealthTeams | Series A | 7.3M |
| 7/2021 | Insight Lifetech | Series D | 85M |
| 12/2020 | Insight Lifetech | Series C | 27.6M |
| 3/2018 | DST Car | Series A | 47.8M |
| 11/2017 | Berry Oncology | Series A | 121.2M |
| 8/2018 | TUNGEE | Series A | 6.3M |
| 9/2012 | Mafengwo | Series B | 15M |
| 11/2021 | ROX Motor | Series C | 100M |
| 6/2018 | Xiaoy Technology | Series B | 4.7M |
| 1/2022 | Ceptur Therapeutics | Series A | 0 |
| 9/2011 | Beijing Centre Biology | Series A | 7.4M |
| 12/2014 | CANbridge Pharmaceuticals | Series A | 10M |
| 8/2018 | Nice Tuan | Seed Round | 0 |
| 9/2011 | Beva | Series A | 3.1M |
| 11/2020 | Asieris Pharmaceuticals | Series D | 0 |
| 3/2021 | imToken | Series B | 30M |
| 9/2015 | Wealth Bridge | Series C | - |
| 8/2011 | Nurotron Biotechnology | Series B | 6.9M |
| 11/2014 | Nurotron Biotechnology | Series C | 1.2M |
| 5/2008 | Oriental Cambridge Education Group | Venture Round | 1M |
| 3/2022 | Medilink Therapeutics | Series B | 70M |
| 3/2019 | RedDoorz | Series B | 0 |
| 10/2021 | ShouTi | Series B | 0 |
| 9/2018 | MicroPoint Bioscience | Series E | 109M |
| 1/2017 | Shenogen Pharma Group | Series D | 45M |
| 8/2014 | Qiniu | Series C | - |
| 12/2018 | Microtech Medical | Series C | 29.1M |
| 4/2021 | SinoUnited Health Clinic | Series C | 30.7M |
| 6/2019 | Pratilipi | Series B | 15.2M |
| 8/2018 | ANXIN | Series B | 19.1M |
| 10/2017 | Bang Er Orthopedic | Series C | 33.9M |
| 5/2019 | SinoUnited Health Clinic | Series B | 9.3M |
| 5/2018 | Heika | Series B | 10.3M |
| 7/2019 | Dingdong Maicai | Series B | - |
| 12/2019 | Newsoara | Series B | 22M |
| 6/2017 | Miaoshou Doctor | Series B | 10.9M |
| 3/2016 | JHT TCM Clinics | Series B | 1.5M |
| 4/2019 | INXX | Series B | 16.5M |
| 11/2015 | ET Healthcare | Series B | - |
| 3/2018 | Coffee Box | Series B | 88M |
| 1/2023 | Yike Polymers | Series B | - |
| 1/2022 | WoXiaoYa | Series B | - |
| 2/2019 | Zuiyou | Series C | 80M |
| 4/2021 | Alpha Biopharma | Series B | 25M |
| 7/2008 | Tigermed | Series A | 6.3M |
| 12/2014 | SequoiaDB | Series A | 10M |
| 3/2014 | Sanyou Medical | Series A | - |
| 7/2017 | Sino Biological | Series A | 29.4M |
| 1/2017 | Qkuts | Seed Round | 1M |
| 3/2016 | Seven Kilometers | Series A | 5M |
| 2/2016 | Microtech Medical | Series A | 24.3M |
| 3/2019 | LuPu Investment | Series A | 44.6M |
| 12/2014 | Luoji Siwei | Series A | - |
| 3/2010 | Arrail Dental Clinic | Series A | 20M |
| 6/2016 | CMLabs | Series B | 14.1M |
| 6/2018 | Pop Game | Seed Round | - |
| 8/2021 | Neuro3 Therapeutics | Seed Round | 10M |
| 11/2013 | Meitu | Seed Round | 5M |
| 4/2018 | Meituan | Venture Round | - |
| 12/2021 | Frontis | Seed Round | 18.4M |
| 11/2021 | Bioyond Tech | Seed Round | 7.8M |
| 7/2020 | XSKY Data Technology | Series D | 33M |
| 12/2019 | SinoUnited Health Clinic | Series C | 8.1M |
| 7/2016 | SequoiaDB | Series B | 10M |
| 1/2008 | 9DIAMOND | Series A | 9.6M |
| 5/2013 | Berry Genomics | Series B | 14.7M |
| 4/2020 | Cadent Therapeutics | Series B | 15M |
| 8/2010 | eHi Car Rental | Series C | 70M |
| 2/2020 | InfStones | Series A | 10M |
| 1/2021 | Vistel | Series B | 9.3M |
| 4/2022 | CIX Technology | Angel Round | - |
| 11/2021 | Platelet BioGenesis | Series B | 75.5M |
| 7/2018 | Madaket | Series B | 0 |
| 9/2019 | Amphivena Therapeutics | Series C | 0 |
| 5/2017 | Wacai.com | Series C | 0 |
| 1/2015 | Bilibili | Series B | 44.2M |
| 7/2015 | Zhaolu Tianxia Wang | Series B | 3.2M |
| 6/2006 | Fangtek | Series C | 12M |
| 7/2017 | Akulaku | Series B | 24.8M |
| 7/2015 | Wacai.com | Series B | 80M |
| 12/2015 | HyperStrong | Series A | 20.3M |
| 12/2020 | WT Microtech Medical | Series D | 0 |
| 1/2015 | Zhaosuliao | Series A | 20M |
| 3/2013 | Origene Technologies | Series C | 21.3M |
| 6/2014 | MOGU | Series D | 200M |
| 9/2021 | XellSmart | Seed Round | 11.9M |
| 4/2016 | ACEA BIO | Series E | 6M |
| 5/2014 | Crown Bioscience | Series D | 26.6M |
| 8/2020 | Connect Biopharmaceuticals | Series C | 115M |
| 4/2021 | Gaugene | Series A | 4.6M |
| 1/2023 | Biotree | Series A | - |
| 2/2017 | Ark Biosciences | Series A | 8M |
| 4/2019 | Coffee Box | Series B | 30.6M |
| 6/2018 | Ark Biosciences | Series B | 32M |
| 3/2015 | Mafengwo | Series C | 100M |
| 11/2011 | Zhihu | Series A | 8M |
| 1/2017 | Zhihu | Series D | 103.3M |
| 7/2018 | Moretickets | Series C | 61.7M |
| 10/2019 | dMed | Series B | 50M |
| 11/2018 | WorkTrans | Series B | 23M |
| 1/2021 | WeRide | Series B | 0 |
| 8/2021 | Matrixport | Series C | 0 |
| 5/2019 | ZuzuChe | Series C | 26.1M |
| 7/2011 | Fanli | Series A | 10M |
| 1/2022 | EigenCOMM | Series C | 157.3M |
| 1/2019 | NASN Automotive Electronics | Series B | 59.6M |
| 8/2013 | Shenogen Pharma Group | Series C | 20M |
| 9/2019 | DST Car | Venture Round | 30M |
| 9/2020 | InventisBio | Series D | 0 |
| 5/2021 | Valgen Medtech | Series B | 188M |
| 9/2008 | ChinaCache | Series C | - |
| 11/2015 | ACEA BIO | Venture Round | 30M |
| 12/2016 | WT Microtech Medical | Series B | - |
| 4/2016 | Insta360 | Series B | - |
| 9/2019 | Insilico Medicine | Series B | 37M |
| 5/2016 | Bilibili | Series C | 199.3M |
| 7/2011 | Xiaomi | Series A | 41M |
| 12/2011 | Xiaomi | Series B | 90M |
| 4/2008 | Nurien Software | Series A | 15M |
| 7/2011 | VANCL | Series F | 230M |
| 5/2016 | Musical.ly | Series C | 133.5M |
| 7/2022 | Ark Biosciences | Series D | - |
| 3/2019 | Abbisko Therapeutics | Series B | 42M |
| 4/2021 | Axera | Seed Round | - |
| 11/2017 | Twine Health | Series A | 1.5M |
| 7/2015 | Tiebaobei | Series B | 16.2M |
| 11/2013 | Tiebaobei | Series A | - |
| 5/2017 | Sinocelltech | Series A | 29M |
| 10/2021 | Clounix | Angel Round | - |
| 12/2014 | Meitu | Series C | 190M |
| 7/2021 | Petkit | Series D | 60M |
| 11/2021 | GenEdit | Angel Round | 9M |
| 11/2019 | Genius | Series B | 14.2M |
| 4/2021 | Abogen Biosciences | Series B | 91.6M |
| 1/2022 | Zhenge Biotech | Series C | 100M |
| 2/2019 | Petkit | Series C | 20M |
| 6/2021 | Hesai Technology | Series D | 300M |
| 9/2020 | Petkit | Series C | - |
| 6/2009 | Novast | Series B | 25M |
| 2/2023 | Oricell Therapeutics | Series B | 0 |
| 10/2015 | CANbridge Pharmaceuticals | Series A | 10M |
| 3/2018 | LetsGetChecked | Series A | 12M |
| 2/2014 | ITutorGroup | Series B | 100M |
| 1/2019 | Antengene Corporation | Series B | 0 |
| 4/2019 | Structure Therapeutics | Series A | 16M |
| 8/2019 | MyHealthTeams | Series B | 0 |
| 6/2012 | Xiaomi | Series C | 216M |
| 1/2009 | Nurien Software | Series A | 10M |
| 3/2023 | TandemAI | Series A | 0 |
| 6/2017 | Zai Lab | Series C | 30M |
| 7/2017 | Kezar Life Sciences | Series B | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 1/2021 | Abbisko Therapeutics | Series D | 123M |
| 2/2022 | GluBio Therapeutics | Series A | 0 |
| 11/2015 | CanSinoBIO | Series C | 30M |
| 10/2021 | Structure Therapeutics | Series B | 0 |
| 2/2017 | Jacobio Pharmaceuticals | Series B | - |
| 4/2023 | Bioyond Tech | Series A | 0 |
| 9/2022 | XellSmart | Series A | - |
| 1/2019 | Schrödinger | Series E | 0 |
| 7/2022 | Gaugene | Series B | 0 |
| 9/2018 | SequoiaDB | Series C | 0 |
| 12/2017 | Tiebaobei | Series C | - |
| 3/2020 | Abbisko Therapeutics | Series C | 70M |
| 8/2022 | OriginCell | Series B | 0 |
| 12/2019 | OriginCell | Series A | 7.1M |
| 12/2016 | Shulan Health | Series B | 31.2M |
| 11/2018 | Genor Biopharma | Venture Round | 276.7M |
| 2/2021 | Liangyihui | Series C | 0 |
| 8/2017 | New Horizon Health | Series B | 20M |
| 1/2023 | Singular Medical | Series B | - |
| 3/2021 | IntoCare | Secondary Market | 4.3M |
| 9/2019 | Hesai Technology | Series C | 1.1M |
| 1/2010 | YPX Cayman Holdings | Series A | 10M |
| 12/2019 | Clinflash Heathcare Technology | Series A | 4.3M |
| 3/2020 | Xueba100.com | Convertible Note | 22.7M |
| 12/2016 | Finern | Series A | 7.3M |
| 3/2020 | ShouTi | Series A | 26M |
| 6/2015 | Cehome | Series B | 2.5M |
| 1/2016 | HyperStrong | Series B | 68.5M |
| 6/2021 | BrainHealth | Series C | 72.4M |
| 5/2014 | Broncus Technologies | Venture Round | 4.3M |
| 10/2008 | T4GAME | Series A | 3M |
| 12/2018 | Xiudan | Seed Round | 3M |
| 2/2021 | Wholee | Series A | 10k |
| 3/2015 | Bioon.com | Series A | 2.9M |
| 4/2018 | KangBai | Series A | 3.7M |
| 12/2021 | Clinflash Heathcare Technology | Venture Round | 15.5M |
| 5/2018 | Bang Er Orthopedic | Series C | 15.8M |
| 3/2021 | Basecamp Bio | Angel Round | 14M |
| 8/2021 | Yunqi | Seed Round | 31M |
| 12/2021 | Sinogen Biopharma | Venture Round | 3M |
| 5/2019 | Zaojiu | Venture Round | 2M |
| 7/2013 | Hortor | Series A | 2.5M |
| 11/2018 | Mucho Indonesia | Seed Round | 3M |
| 9/2021 | ROX Motor | Series B | 60M |
| 12/2011 | Beijing GoodWill Technology | Series A | 4.2M |
| 11/2018 | WebComics | Seed Round | 3.2M |
| 5/2017 | DST Car | Seed Round | 7.3M |
| 11/2018 | Webuy Group | Series B | 15.8M |
| 10/2015 | Wuxi Vision Pro | Series A | 4.8M |
| 6/2022 | Insilico Medicine | Series D | 0 |
| 8/2016 | Xiutao | Seed Round | 1.5M |
| 8/2021 | Lingyi Zhihui | Series B | 0 |
| 12/2019 | Inbilin | Venture Round | - |
| 8/2022 | GluBio Therapeutics | Series A | 0 |
| 8/2022 | OriginCell | Series B | 0 |
| 8/2022 | Oricell Therapeutics | Series B | 0 |
| 7/2022 | Chatail | Series B | 0 |
| 7/2022 | CIX Technology | Seed Round | - |
| 7/2022 | Biotree | Series A | 0 |
| 7/2022 | Gaugene | Series B | 0 |
| 7/2022 | Ark Biosciences | Series D | - |
| 6/2022 | LaNova Medicines | Series B | - |
| 6/2022 | Insilico Medicine | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
